SOLACI-SBHCI 2016 Presentations

Left-Main Disease: When is PCI the Preferred Strategy?

solaci
solaci
428
0

Por Dr. Rafael Cavalcante.

Rafaael Cavalcante
Previous article
Reserva Fracionada de Fluxo na Avaliação da Doença Coronariana Multivascular Complexa
Next article
Passo a Passo para Realização de uma Avaliação Funcional Adequada com FFR
solaci
solaci

More articles by this author

Venus P-Valve: The valve and initial clinical worldwide experience

solaci - 0
Por Dr. Alejandro Peirone.

FFR EM LESÕES SEQUENCIAIS E DOENÇA DIFUSA

solaci - 0
Por Dr. Silvio Gioppato.  

Erros mais comuns na realização do FFR: como identificá-los e preveni-los

solaci - 0
Por Dr. Fernando Mendes Sant’Anna.  

Análise Crítica do Estudo Leaders É o melhor stent que temos?

solaci - 0
Por Dr. Esmeralci Ferreira.  

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Dr. Omar Tupayachi - 0
Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Dr. Juan Manuel Pérez - 0
Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

Dr. Andrés Rodríguez - 0
After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...